118 related articles for article (PubMed ID: 22921577)
1. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
[TBL] [Abstract][Full Text] [Related]
2. Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial.
Sharp L; Cotton S; Thornton A; Gray N; Whynes D; Smart L; Waugh N; Duncan I; Cruickshank M; Little J;
Cytopathology; 2012 Jun; 23(3):150-60. PubMed ID: 21366734
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial.
Sharp L; Cotton S; Little J; Gray NM; Cruickshank M; Smart L; Thornton A; Waugh N; Walker L;
PLoS One; 2013; 8(12):e80092. PubMed ID: 24386076
[TBL] [Abstract][Full Text] [Related]
4. A normal colposcopy examination fails to provide psychological reassurance for women who have had low-grade abnormal cervical cytology.
Cotton SC; Sharp L; Little J; Gray NM; Walker LG; Whynes DK; Cruickshank ME;
Cytopathology; 2015 Jun; 26(3):178-87. PubMed ID: 25099940
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA).
Sharp L; Cotton S; Carsin AE; Gray N; Thornton A; Cruickshank M; Little J;
Psychooncology; 2013 Feb; 22(2):368-80. PubMed ID: 22162138
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.
Fielding S; Rothnie K; Gray NM; Little J; Cruickshank ME; Neal K; Walker LG; Whynes D; Cotton SC; Sharp L;
Psychooncology; 2017 Apr; 26(4):476-483. PubMed ID: 27297097
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
8. Can default rates in colposcopy really be reduced?
Balasubramani L; Orbell S; Hagger M; Brown V; Tidy J
BJOG; 2008 Feb; 115(3):403-8. PubMed ID: 18190379
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Worries after Colposcopy: Which Women Are at Increased Risk?
Sharp L; Cotton SC; Cruickshank ME; Gray NM; Neal K; Rothnie K; Thornton AJ; Walker LG; Little J;
Womens Health Issues; 2015; 25(5):517-27. PubMed ID: 26051021
[TBL] [Abstract][Full Text] [Related]
10. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
12. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.
Miller SM; Siejak KK; Schroeder CM; Lerman C; Hernandez E; Helm CW
J Natl Cancer Inst; 1997 May; 89(10):703-8. PubMed ID: 9168185
[TBL] [Abstract][Full Text] [Related]
13. Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature.
Lester H; Wilson S
Br J Gen Pract; 1999 Mar; 49(440):223-9. PubMed ID: 10343430
[TBL] [Abstract][Full Text] [Related]
14. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
16. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears.
Kitchener HC; Burns S; Nelson L; Myers AJ; Fletcher I; Desai M; Dunn G; Maguire P
BJOG; 2004 Jan; 111(1):63-70. PubMed ID: 14687054
[TBL] [Abstract][Full Text] [Related]
18. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
19. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
